Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/Bf1f34b833a42cf2689c972ed9fc8eaf3> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- Bf1f34b833a42cf2689c972ed9fc8eaf3 NCIT_P378 "NCI" @default.
- Bf1f34b833a42cf2689c972ed9fc8eaf3 type Axiom @default.
- Bf1f34b833a42cf2689c972ed9fc8eaf3 annotatedProperty IAO_0000115 @default.
- Bf1f34b833a42cf2689c972ed9fc8eaf3 annotatedSource NCIT_C188312 @default.
- Bf1f34b833a42cf2689c972ed9fc8eaf3 annotatedTarget "A bispecific antibody directed against both the tumor-associated antigen (TAA) CD19 and the co-stimulatory T-cell-specific surface glycoprotein CD28, with potential immunostimulating and antineoplastic activities. Upon administration, anti-CD19/CD28 bispecific antibody RO7443904 targets and binds to both CD28 expressed on T-cells and CD19 expressed on tumor cells, which crosslinks the T-cells to the tumor cells. This may result in a potent cytotoxic T-lymphocyte (CTL) response against the CD19-expressing tumor cells. CD19 antigen is a B-cell specific cell surface antigen overexpressed in B-cell lineage malignancies." @default.